The Impact of Bariatric Surgery on Comorbidities and Medication Use Among Obese Patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The risks and benefits of bariatric surgery have rarely been evaluated in large multiyear patient samples. This study identifies the short- and long-term impact of bariatric surgery on comorbidities and medication use among obese patients.
A comprehensive analysis of 5,502 obese patients who underwent bariatric surgery was performed. Submissions of reimbursement claims, including diagnostics and medication use, were compared in the 90 days preceding the surgery and 30 up to 1,110 days following the surgery. Presurgery and postsurgery frequency counts were performed on diagnostics and medication use to identify trends.
Among 5,502 patients, significant decreases in the prevalence of reported comorbidities were observed during the short-term postsurgery period and sustained for up to 3 years of follow-up. Compared to the presurgery period, significant decreases (p < 0.05) were observed after 3 years for total cardiovascular disorders (43.6% vs. 14.2%), diabetes mellitus (19.9% vs. 7.7%), chronic obstructive pulmonary disease and other respiratory conditions (57.7% vs. 16.2%), diseases of the musculoskeletal system and connective tissue (32.6% vs. 27.7%), and mental disorders (30.7% vs. 14.8%). Over the same period, the frequency of medication use decreased significantly for a number of conditions including infections, pain, respiratory, cardiovascular, gastroenterologic, lipidemic, and diabetic conditions. Anemia, however, increased from 3.8% to 9.9%, and use of nutritional supplements increased significantly.
Bariatric surgery was associated with significant reductions in reported claims for short- and long-term health outcomes and reduced medication use for major disease categories.
- Yanovski, SZ, Yanovski, JA (2002) Obesity. N Engl J Med 346: pp. 591-602 CrossRef
- Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 115: pp. 956-61
- García-Zakzuk, B. 2005. Medical and Rx technologies—what’s in the pipeline. Society of Actuaries Record, vol. 31 (no. 2).
- The American Society for Metabolic and Bariatric Surgery. 2009. Fact sheet: metabolic and bariatric surgery. http://www.asmbs.org/Newsite07/media/asmbs_fs_surgery.pdf. Accessed 16 November 2009.)
- Buchwald, H, Avidor, Y, Braunwald, E (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292: pp. 1724-37 CrossRef
- Christou, NV, Sampalis, JS, Liberman, M (2004) Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240: pp. 416-23 CrossRef
- Sjostrom, L, Lindroos, AK, Peltonen, M (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: pp. 2683-93 CrossRef
- Hodo, DM, Waller, JL, Martindale, RG (2008) Medication use after bariatric surgery in a managed care cohort. Surg Obes Relat Dis 4: pp. 601-607 CrossRef
- Ninh, T, Nguyen, J, Varela, E (2006) Reduction in prescription costs after laparoscopic gastric bypass. Am Surg 72: pp. 853-6
- Narbro, K, Agren, G, Jonsson, E (2002) Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 162: pp. 2061-9 CrossRef
- Zingmond, D, McGory, M, Ko, C (2005) Hospitalization before and after gastric bypass surgery. JAMA 294: pp. 1918-24 CrossRef
- Ukleja, A, Stone, RL (2004) Medical and gastroenterologic management of the post-bariatric surgery patient. J Clin Gastroenterol 38: pp. 312-21 CrossRef
- Ledoux, S, Msika, S, Moussa, F (2006) Comparison of nutritional consequences of conventional therapy of obesity, adjustable gastric banding, and gastric bypass. Obes Surg 16: pp. 1041-9 CrossRef
- Segal, JB, Clark, JM, Shore, AD (2009) Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg 19: pp. 1646-1656 CrossRef
- Wilchesky, M, Tamblyn, R, Huang, A (2004) Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 57: pp. 131-141 CrossRef
- Zizza, CA, Herring, AH, Stevens, J (2003) Bariatric surgeries in North Carolina, 1990 to 2001: a gender comparison. Obes Res 11: pp. 1519-25 CrossRef
- The Impact of Bariatric Surgery on Comorbidities and Medication Use Among Obese Patients
Volume 20, Issue 7 , pp 861-870
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Morbid obesity
- Quality of life
- Bariatric surgery
- Cardiovascular disease
- Diabetes mellitus
- Industry Sectors
- Author Affiliations
- 3. Analysis Group, 111 Huntington Avenue, Tenth Floor, Boston, MA, 02199, USA
- 1. Service des Explorations Fonctionelles—Hôpital Louis Mourier (AP-HP), Colombes and UFR de Médecine, Université Paris 7, Paris, France
- 2. Hôpital Hotel-Dieu (AP-HP), Paris, France